Tech Company Financing Transactions
Vedantra Pharmaceuticals Funding Round
Access BridgeGap Ventures and private investors participated in a $3.3 million capital raise for Vedantra Pharmaceuticals. This venture round was announced on 8/4/2012.
Transaction Overview
Company Name
Announced On
8/4/2012
Transaction Type
Venture Equity
Amount
$3,300,000
Round
Undisclosed
Investors
Access BridgeGap Ventures (Daniel Behr)
Proceeds Purpose
Proceeds purposes were not disclosed. SEC regulatory filing.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
1 Kendall Sq. Bldg. 1400 14303
Cambridge, MA 02139
USA
Cambridge, MA 02139
USA
Phone
Website
Email Address
Not Recorded
Overview
Vedantra Pharmaceuticals is applying novel nanotechnology-based approaches to develop vaccines for infectious disease and cancer.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chairman
Julian Adams
Co-Founder
Satish Jindal
Founder
Darrell Irvine
VP - R & D
Peter DeMuth
Browse more venture capital transactions:
Prev: 8/4/2012: One Jackson venture capital transaction
Next: 8/4/2012: EarlyShares venture capital transaction
Share this article
About Database of VC Transactions
We do our best to report on every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The information is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs